Cargando…

Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain

PURPOSE: A systematic, standardized collection of health outcomes during patient treatment and follow-up, relevant from the perspective of all stakeholders, is a crucial step toward effective and efficient disease management. This project aimed to define a standard set of health outcomes for patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arrazubi, Virginia, Cajaraville, Gerardo, Cantero, David, Giralt, Jordi, Mesia, Ricard, Monje, Florencio, Rueda, Antonio, Sistiaga, Alexander, Suarez, Jorge, Mut, Alejandro, Comellas, Marta, Lizán, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819151/ https://www.ncbi.nlm.nih.gov/pubmed/35141139 http://dx.doi.org/10.3389/fonc.2021.747520

Ejemplares similares

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019)

SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
por: Rueda Domínguez, Antonio, et al.
Publicado: (2022)

Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()
por: de Llobet, Lara I., et al.
Publicado: (2014)

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
por: Guigay, Joël, et al.
Publicado: (2019)

Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population
por: Fernández-Mateos, Javier, et al.
Publicado: (2019)

Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma
por: Fernández-Mateos, Javier, et al.
Publicado: (2017)

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice
por: Falco, Agustín, et al.
Publicado: (2021)

Additional Value of Patient-Reported Symptom Monitoring in Cancer Care: A Systematic Review of the Literature
por: Lizán, Luís, et al.
Publicado: (2021)

p16, HPV, and Cetuximab: What Is the Evidence?
por: Bonner, James A., et al.
Publicado: (2017)

Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
por: Arribas, Lorena, et al.
Publicado: (2021)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
por: Martinón-Torres, Federico, et al.
Publicado: (2022)

Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature
por: Belinchón, I, et al.
Publicado: (2016)

Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma
por: García-Foncillas, Jesús, et al.
Publicado: (2022)

Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
por: Fernández-Mateos, Javier, et al.
Publicado: (2020)

An unusual neck tumor in a young pregnant woman: challenge diagnosis and response to treatment
por: Arango, Juan F., et al.
Publicado: (2017)

HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma
por: Coleman, Niamh, et al.
Publicado: (2023)

Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature
por: Torre-Alonso, Juan Carlos, et al.
Publicado: (2018)

Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation
por: Wildsmith, Sophie, et al.
Publicado: (2022)

Preclinical models in head and neck squamous cell carcinoma
por: Chaves, Patricia, et al.
Publicado: (2023)

The Perspective of Patients and Health Professionals on the Prioritization of Assisted Reproductive Techniques. The PRIOFER Study
por: Lizán Tudela, César, et al.
Publicado: (2023)

Functional Results of Transverse Extended Incision in Cervical Neck Dissection
por: Chiesa-Estomba, Carlos Miguel, et al.
Publicado: (2021)

Head and neck cancer in times of COVID-19: Emotion-based medicine()
por: Sistiaga Suárez, J. Alexander, et al.
Publicado: (2021)

Multidisciplinary expert consensus on secondary fracture prevention in Spain
por: Casado, E., et al.
Publicado: (2021)

SEOM clinical guidelines for the treatment of head and neck cancer (2017)
por: Iglesias Docampo, L. C., et al.
Publicado: (2017)

Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Gogate, Anagha, et al.
Publicado: (2023)

TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
por: Rubió-Casadevall, Jordi, et al.
Publicado: (2023)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
por: Lizán, Luis, et al.
Publicado: (2014)

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma
por: Hamoir, Marc, et al.
Publicado: (2018)

Calibrated prevalence of disabling chronic pain according to different approaches: a face-to-face cross-sectional population-based study in Southern Spain
por: Cabrera-León, Andrés, et al.
Publicado: (2017)

Plasma Vascular Endothelial Growth Factor Dysregulation in Defining Aggressiveness of Head and Neck Squamous Cell Carcinoma
por: Kulapaditharom, Boonchu, et al.
Publicado: (2012)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
por: Michmerhuizen, Nicole L., et al.
Publicado: (2022)

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
por: Harrington, Kevin J., et al.
Publicado: (2023)

Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment
por: Garcia-Dominguez, José Manuel, et al.
Publicado: (2016)

The Impact of Patient Support Programs in Europe: A Systematic Literature Review
por: Sacristán, José Antonio, et al.
Publicado: (2022)

Recommendations of the Spanish Society of Otolaryngology and Head and Neck Surgery for Performing Tracheotomies in Patients Infected by the Coronavirus, Covid-19()
por: Díaz de Cerio Canduela, Pedro, et al.
Publicado: (2020)

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wildsmith, Sophie, et al.
Publicado: (2023)

4373 Defining the role of non-canonical PIK3CA mutations in head and neck squamous cell carcinoma
por: Lee, Michelle Ji-Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uq3qsqcq2918ne97jfd1uhnav3